Product NDC: | 65862-617 |
Proprietary Name: | Quinapril |
Non Proprietary Name: | Quinapril Hydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; Quinapril Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-617 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202725 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130429 |
Package NDC: | 65862-617-99 |
Package Description: | 1000 TABLET, FILM COATED in 1 BOTTLE (65862-617-99) |
NDC Code | 65862-617-99 |
Proprietary Name | Quinapril |
Package Description | 1000 TABLET, FILM COATED in 1 BOTTLE (65862-617-99) |
Product NDC | 65862-617 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Quinapril Hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20130429 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | QUINAPRIL HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |